Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
63 min
Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46) Bispecific Antibodies — Dr Lonial (19:16) Antibody-Drug Conjugates — Dr Richardson (37:08) Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10) CME information and select publications (https://researchtopractice.com/activity/integrating-new-advances-into-community-oncology-practice-6/)
Episode information is provided by the publisher. Listening takes place on the publisher’s service.
For additional nuances, references, and early access to content, see the StayCurious Metabolism Newsletter: https://staycuriousmetabolism.substack.com/p/hijacking-cancer-to-kill-alzheimers?r=40ekz2 Check out this link to access our StayCurious Brain Health Archives: https://staycuriousmetabolism.substack.com/p/brainhealth Omega-3 and Brain Health Video: https://youtu.be/B-kEn0FukXM To try the Accentrate Omega Max supplement containing LPC-DHA, click here: https://www.fenixhealthscience.com/staycurious Lithium Brain Health Video: https://youtu.be/Hcz0Eyp1LE4 NAD+ Brain Health Letter: https://staycuriousmetabolism.substack.com/p/never-get-alzheimers-disease-the?r=40ekz2 A new paper published in Cell reveals an unexpected biological connection between cancer and Alzheimer’s disease—one that challenges long-held assumptions about both. In this video, MD-PhD neuroscientist Nick Norwitz walks through the actual data behind the study, showing how proteins secreted by cancer cells reduced amyl
"Curing cancer," explained. We’re not looking for a “cure for cancer” anymore. Cancer is hundreds of diseases, so we’re really in a multi front fight against all of them. Cancer is a problem for us today in a way it wasn’t for previous generations. But, luckily, we also have more and more ways to fight back. I started this episode with endless questions: What is cancer? What causes it? How do we treat cancer? What are the symptoms? Why are some cancers easier to treat than others? Why is cancer so hard to cure? Why do so many people die of cancer? What I found is an incredible, complex, inspiring effort to treat and stop an insidious killer. In this video, we dive deep into how we treat cancer today. But I also found that we may not be helping the greatest number of people we can. In this episode of Huge If True, I want to make the case that while we have made enormous strides in the fight against cancer we have also largely ignored one of the single best ways to save the most lives. I
Keto Consult #12, This week Jennifer and I talk about my experience at the Metabolic Health Center 2019. I was able to hear some really interesting lectures about Keto for Cancer and Keto for Mental Health. The talk about Keto for Cancer and Keto for Mental Health has come such a long way in the past 2 years and continues to evolve. We also discuss the Effects of Marijuana on the Brain and Hyperbaric Oxygen Chambers and the benefits of Hyperbaric Oxygen Therapy. Finally we get an update from Jennifer and discuss her personal Keto Journey. Thanks for tuning into my channel. To learn more about Keto and Cancer, read my blog here: https://bozmd.com/m-d-anderson-on-the-keto-diet-and-cancer/ BOOK-LINK - ANYWAY YOU CAN. AUDIBLE: https://adbl.co/2SLLfS1 PAPERBACK= (Affilate link) https://amzn.to/2Cq1IVC The two most common questions I get ... 1) "Doc, what BLOOD METER do you recommend?" ANSWER: FORACARE: http://bit.ly/2QKGmKG For years my diabetics told me this system was great. I tried sever
THE SEARCH FOR THE ULTIMATE RED LIGHT THERAPY IS OVER! After decades of exploring wellness technologies, Michael Jaco sits down with Rob Rene, founder of Exodus Strong, to explore the Red Light+ Total Body Reset system, the science behind red and near-infrared light, and why this technology has become such an important part of their wellness conversation. Rob's remarkable personal journey—including surviving five near-death experiences—inspired his mission to develop practical wellness tools that people can incorporate into their everyday lives. Discover the full-body Red Light+ Mat, designed for convenient 20-minute sessions, and the portable Red Light+ Wand, created for targeted use on areas such as the knees, shoulders, hands, and lower back. Michael and Rob discuss the technology, personal experiences, and how red light therapy may support a daily wellness routine. BLACK FRIDAY–CYBER MONDAY LISTENER EXCLUSIVE! This is your opportunity to explore Exodus Strong's special holiday offe
Introducing the “Facts From the Frontlines” episode of #TheTonyRobbinsPodcast – where Tony uncovers the truth about coronavirus with a 7-person panel of highly qualified researchers, an experienced epidemiologist, a Nobel Laureate, and M.D.s testing and treating patients on the frontlines. Together, they reveal the evidence-based research that has come to light in the last two months. Uploaded 23-05-20 This is one of the most important interviews Tony has ever conducted. It reminds us to stand guard at the door of our mind, practice discernment when determining trustworthy sources, and think critically in order to stay flexible and maintain the ability to pivot in light of new information – especially when lives depend on it. To hear the full interview, go here: https://www.tonyrobbins.com/podcasts/covid-19-facts-from-the-frontline/ *COVID-19 Playlist* https://www.youtube.com/watch?v=YgP_Au5RZVw&list=PLYTXvUDQT5pUaoPTzi71UIqilqgBOKkQe (https://www.youtube.com/watch?list=PLYTXvUDQT5pUao
What actually works when it comes to detecting lies, and why are so many popular ideas about reading people and nonverbal behavior at odds with the scientific research? I talk with Aldert Vrij, one of the world's leading deception-detection researchers, who has spent almost four decades studying these topics. We discuss why what people say is far more revealing than their body language; why the perceived “sexiness” of reading nonverbal behavior has contributed to widespread myths and misconceptions; whether vocal behaviors like pitch, volume, and hesitation contain meaningful clues; and whether there's value in analyzing minor word choices and turns of phrase, as is done in so-called “statement analysis.” We discuss Paul Ekman's legacy as a source of faulty ideas about deception, micro-expression-based deception detection training, and the strategies that popular “body language experts” use to appear scientifically credible while simultaneously promoting ideas that conflict with the sc
Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics: Introduction (0:00) Prologue: Saturday Night Fever (1:35) Baby Boomers' Guide to Mechanisms of Action (3:07) Second-Line Treatment (12:36) Complications Associated with Bispecific Antibodies (23:41) Case Presentations (25:52) New Bispecific T-Cell Engagers — Surovatamig (26:24) Other Novel Agents (50:05) CME information and select publications (https://researchtopractice.com/BispecificsFL2026)
Featuring an interview with Dr Matthew Lunning, including the following topics: Bispecific antibody/antibody-drug conjugate combinations (0:00) A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07) CME information and select publications (https://researchtopractice.com/ASCO2026/NHL/Micro/2)
Featuring a presentation by Dr Matthew Matasar, including the following topics: Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00) Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41) Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01) Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47) Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34) Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31) Discussion of Questions from the Community (50:20) CME information and select publications (https://researchtopractice.com/GR2026/DLBCL)
Colleges should publish clear information about costs and likely graduate outcomes.
Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.
Do you agree or disagree?
Common Quandary
A Common Quandary to discuss
Another conversation to explore, separate from this news story.
A donor's family wants to hear their loved one's heart beating in you. Do you meet them?
A transplant recipient receives a letter from the donor's family asking to meet. The recipient feels profound gratitude but also discomfort and wants their recovery to remain private and separate from another family's grief.
Can receiving an extraordinary gift create a personal obligation to strangers?